Enhancing Extraction Yield of Chlorella Extract by Enzyme Treatment

  • In, Man-Jin (Department of Human Nutrition and Food Science, Chungwoon University) ;
  • Jang, Jae-Eun (Department of Human Nutrition and Food Science, Chungwoon University) ;
  • Kim, Dong-Ho (FNBio Co. Ltd.)
  • Published : 2007.09.30

Abstract

An efficient production method of chlorella extract was developed by enzymatic treatment using cell lytic and proteolytic enzymes. The suitable dosage of Tunicase, a cell lytic enzyme, was found to be 1.0% (w/w). Proteolytic enzymes were screened to obtain high chlorella growth factor (CGF) index, which indicates crude CGF content and solid recovery. Among the seven tested proteases, Esperase, whose optimal dosage was 1.0% (w/w), was selected. By co-treatment using optimal dosages of Tunicase and Esperase, the highest CGF index and solid recovery were obtained. The CGF index and solid recovery of co-treatment were remarkably enhanced by 250 ($4.36{\rightarrow}15.21$) and 220% ($12.65%{\rightarrow}40.15%$), respectively, than those of the non-treated extracts.

Keywords

References

  1. Chae HJ, In MJ, and Kim MH (1997) Optimization of enzymatic treatment for the production of hydrolyzed vegetable protein. Korean J Food Sci Technol 29, 1125-1130
  2. Chae HJ, Joo H, and In MJ (2001) Utilization of brewer's yeast cells for the production of food-grade yeast extract. Part 1: effects of different enzymatic treatments on solid and protein recovery and flavor characteristics. Bioresource Technol 76, 253-258 https://doi.org/10.1016/S0960-8524(00)00102-4
  3. Chae HJ and In MJ (2004) Study on utilization of animal by-products from food processing by enzyme treatment. J Korean Soc Appl Biol Chem 47, 197-201
  4. Han JG, Kang GG, Kim JK, and Kim SH (2002) The present status and future of Chlorella. Food Sci Ind 6, 64-69
  5. Hasegawa T, Yoshikai Y, Okuda M, and Nomoto K (1990) Accelerated restoration of the leukocyte nrnnber and augmented resistance against Escherichia coli in cyclophosphamide- treated rats orally administrated with a hot water extract of Chlorella vulgaris. Int J Immunopharmacol 12, 883-891 https://doi.org/10.1016/0192-0561(90)90007-A
  6. Hasegawa T, Okuda M, Nomoto K, and Yoshikai Y (1994) Augmentation of the resistance against Listeria monocytogenes by oral administration of a hot water extract of Chlorella vulgaris in mice. Immunopharmacol Immunotoxicol 16, 191-202 https://doi.org/10.3109/08923979409007090
  7. Hasegawa T, Kimura Y, Hiromatsu K, Kobayashi N, Yamada A, Makino M, Okuda M, Sano T, Nomoto K, and Yoshikai Y (1997) Effect of hot extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes. Immunopharmacology 35, 273-282 https://doi.org/10.1016/S0162-3109(96)00150-6
  8. Hidaka S, Okamoto Y, and Arita M (2004) A hot water extract of Chlorella pyrenoidosa reduces body weight and serum lipids in ovariectomized rats. Phytother Res 18, 164-168 https://doi.org/10.1002/ptr.1178
  9. In MJ, Chae HJ, and Oh NS (2002) Process development for heme-enriched peptide by enzymatic hydrolysis of hemoglobin. Bioresource Technol 84, 63-68 https://doi.org/10.1016/S0960-8524(02)00009-3
  10. In MJ, Kim DC, Chae HJ, and Oh NS (2003) Effects of degree of hydrolysis and pH on the solubility of hemeiron enriched peptide in hemoglobin hydrolysate. Biosci Biotechnol Biochem 67, 356-367
  11. Kim DC, Chae HJ, Oh NS, and In MJ (2001) Effect of cell lytic enzyme on the production of yeast extract. J Korean Soc Appl Biol Chem 44, 273-275
  12. Konishi F, Tanaka K, Himeno K, Taniguchi K, and Nomoto K (1985) Antitumor effect induced by a hot water extract of Chlorella vulgaris (CV): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 19, 73-78
  13. Konishi F, Tanaka K, Kumanoto S, Hasegawa T, Okuda M, Yano I, Yoshikai Y, and Nomoto K (1990) Enhanced resistance against Escherichia coli by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice. Cancer Immunol Immunother 32, 1-7 https://doi.org/10.1007/BF01741717